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10%, BBraun. Rubf, Barcelona-Spain) to activate. The animals 
were sacrificated at 7 and 14 days after to begin the treatment. 
Hematoxyline-Eosine and anti-proliferating cell nuclear antigen 
(PCNA) monoclonal antibody were used to stained the samples 
and to value total cell density and undifferentiated messenchy- 
mal cells respectively in the tissue repair. Statistical for Windows: 
ANOVA Tukey test with p<0,05 was used to statistical analysis. 
Results: At 7 days cell density was higher statistically in PRGF + 
HA and HA respect PCB group, but at 14 days had not statistical 
diferences among three groups. The relation PCNA/Cell Density 
was higher statistically in PCB group than PRGF + HA and HA 
group at 7 days, but at 14 days did not exist (Table 1). 
Table 1 
Group Total Density PCNA-positive cells 
(cells × 10-3/mm 2) (% of total) 
7d~s 14d~s 7d~s 14d~s 
PCB 0.16 ± 0,05 b 0.42 ± 0.07 60.54 ± 21.64 a 15.28 ± 8.39 
HA 0.41 ± 0.08 a 0.39 ± 0.08 8.43 ± 2.80 b 6.10 ± 3.18 
PRGF+HA 0.42±0.13a 0.37±0.16 31.66±27.72b 16.03±6.90 
Values are means ± SD for five animals, a and b P< 0,05 among three 
groups. 
Discussion and Conclussion: PRGF and HA association and 
HA had a tissue repair level more advanced than PCB. At 7 days 
the results showed statistical diferences in both parameters but 
at 14 days the parameters are similar. 
The HA produced an increase in the articular cartilage repair ve- 
locity, although the association with PRGF did not show statistical 
diferences, a major response in the tissue repair with the PRGF 
and HA synergy was seen. 
We think that the undifferentiated cells find in early repair periods 
and the HA and PRGF induce to arrive to a peak of response 
before 7 days. Therefore, we think that it is necessary to make an 
study to evaluate the tissue repair in a shorter period of evolution. 
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Aim of the s tudy Gold sodium thiomalate (aurothiomalate) is 
widely used in the treatment of arthritis. Inducible prostaglandin 
synthase (cyclooxygenase-2, COX-2) and inducible nitric ox- 
ide synthase (iNOS) are expressed in rheumatoid and os- 
teoarthritic artilage and produce high amounts of proinflamma- 
tory prostanoids and nitric oxide (NO) in the joint. In the present 
study we investigated the effects of aurothiomalate on interleukin 
(IL)-I I~ -induced COX-2 and iNOS expression and prostaglandin 
E2 (PGE2) and NO production in immortalized murine H4 chon- 
drocytes*. 
Results Aurothiomalate inhibited IL-11~ -induced COX-2 and 
iNOS expression at mRNA and protein level, and subsequent 
PGE2 and NO production in a dose-dependent manner in chon- 
drocytes. The effect was found at drug concentrations that 
are achieved clinically. Aurothiomalate suppressed also IL-11~ - 
induced activation of NF-KB, which is an important transcription 
factor for both iNOS and COX-2. 
Conclusions Aurothiomalate suppressed IL-1 I~ -induced COX-2 
and iNOS expression in chondrocytes. The results suggest an 
additional anti-inflammatory mechanism for aurothiomalate. 
*Murine H4 chondrocyte cell line was kindly provided by Peter 
van der Kraan from Laboratory of Experimental Rheumatology, 
University Medical Center Nijmegen, Netherlands. 
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Osteoarthritic hondrocytes exhibit abnormal metabolic features. 
These changes consist of reduced content and rate of net syn- 
thesis of proteoglycans (PG), mainly due to increased degrading 
enzymes, including metalloproteinases. Several strategies have 
been utilized in an attempt to replenish this pathological hall- 
mark of osteoarthritis - the depletion of PG- glycosaminoglycans 
(GAG) content, with very limited success. 
Angiotensin converting enzyme (ACE) belongs to the family of 
metalloproteinases, which are involved in the regulation and acti- 
vation of enzymatic systems that cause damage in tissues such 
as cartilage. ACE catalyses the formation of angiotensin II (All) 
from its inactive precursor angiotensin I. All exerts its biologi- 
cal effects via specific cell-surface receptors, AT1 and AT2. The 
above receptors regulate vasoconstriction, stimulate angiogene- 
sis, induce fibroblast proliferation and various growth factor ex- 
pressions. Drugs which belong to the families of ACE inhibitor 
(ACEI) and angiotensin receptor antagonist (blocker) (ARB) in- 
hibit the ailing effects of All on cartilage. 
In the present study, we utilized a system of cultured chon- 
drocytes simulating osteoarthritic conditions (using puromycin, 
puromycin aminonucleoside, IL I~1 & bacterial LPS). Incuba- 
tion of cultured chondrocytes with puromycin (101~g/ml) led to 
a decrease in PG-GAG synthesis to 554-1.5%(4-SD) of con- 
trol. ACEI and ARB treatment restored PG-GAG synthesis 
to 844-16%(4-SD) of control levels, despite the presence of 
puromycin. This implies that inhibition of All may modify the syn- 
thesis of PG-GAG in chondrocytes, and confer beneficial effects 
in this model of osteoarthritis. 
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Aims: Value the active proliferation of mesenchymal cells in rab- 
bit full-thickness defects of articular cartilage after application of 
PRGE 
Methods:  5 mm diameter x 4 mm deph cylindrical defects were 
created in the femoral trochlea of 20 rabbit knees. Ten ani- 
mals received intraarticular injections of activate PRGF and other 
ten with SSF (PCB group) (Fisiol6gico Braun, BBraun. Rubf, 
Barcelona-Spain) even 2 days, being the first injection during the 
surgery. PRGF was obtained after venous blood centrifugation 
and added 5% of CI2Ca (Cloruro C~,lcico Braun 10%, BBraun. 
Rubf, Barcelona-Spain) to activate. The animals were sacrificated 
at 7 and 14 days after to begin the treatment. Hematoxyline- 
Eosine and anti-proliferating cell nuclear antigen (PCNA) mono- 
clonal antibody were used to stained the samples and to value to- 
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tal cell density and undifferentiated messenchymal cells respec- 
tively in the tissue repair. Statistical for Windows: ANOVA Tuckey 
test with p<0,05 was used to statistical analysis. 
Results: At 7 days cell density was higher statistically in PRGF 
group, but at 14 days had not statistical diferences between two 
groups. The relation PCNA/Cell Density was higher statistically 
in PCB group than PRGF group at 7 days, but at 14 days did not 
exist (Table 1 ). 
Table 1 
Group Total Density PCNA-positive cells 
(cells × 10-3/mm 2) (% of total) 
7 days 14 days 7 days 14 days 
PCB 0.16 ± 0.05* 0.42 ± 0.07 60.54 ± 21.64"* 15.28 ± 8.39 
PRGF 0.31 ± 0.13" 0.36 ± 0.07 37.79 ± 26.98** 14.15 ± 7.36 
Values are means ± SD for five animals. 
Discussion and Conclusion: PRGF group showed a level of 
tissue repair more advanced than PCB. At 7 days the results 
showed statistical diferences in both parameters but at 14 days 
the parameters are similar. 
We think that PRGF group had avery early increase of PCNA 
cells in the first days because the undifferentiated cells find in 
early repair periods, and the growth factors cause an increment 
in the velocity repair, reached the peak of PCNA cells before 7 
days. The PCB group reached the peak of PCNA cells around 
7 days, because the repair process was observed slower than 
PRGF group. At 14 days there were not statistical differences be- 
cause after the peak is reached, a decrease in the density of 
PCNA cells exists. 
The more advanced tissue repair was observed in PRGF group 
at 7 days with statistically differences, but were similar at 14 days. 
Therefore, we think that it is necessary to make an study to eval- 
uate the tissue repair in a shorter period of evolution. 
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Purpose: Because of declining recruitment response rates and 
the necessity to screen large populations, efficient screening 
methods may aid study enrollment. We therefore adapted a 
postal survey method to identify hand OA and tested it in our 
outpatient clinics. 
Methods: To begin with, we modified an English survey for nodal 
OA (S. O'Reilly et al., Screening for hand osteoarthritis using a 
postal survey, Osteoarthritis & Cartilage 5:461-465, 1999). Our 
adaptations were to use U. S. terms and describe 1st CMC 
involvement. Later, a second survey version incorporated new 
drawings and a self-examination method. A convenience sample 
of outpatients appearing older than 60 and attending medical clin- 
ics for reasons other than arthritis was given the survey and then 
examined. Two experienced rheumatologists were the examiners 
(GM and MRC). ACR Clinical Hand OA classification criteria were 
used, and statistical analyses were done with SAS. 
Results: Among 352 subjects who completed either survey and 
an exam, hand pain was common (71%). 65% had hand pain 
more than three times in the previous year, and 36% had pain 
lasting longer than a week. By rheumatologist's exam, 41% had 
ACR Clinical Hand OA. Using the first survey (without a self-exam 
method) on 235 subjects, the group with hand OA underreported: 
the mean number of DIP s reported as OA-affected was 1.5, while 
exam showed mean 4.6. Tetrachoric/polychoric orrelation be- 
tween individual joint reports and exams averaged 0.70 with the 
first survey, and mean positive and negative predictive values of 
self-report were 74% and 80%, respectively. With the first survey, 
58 subjects had ACR Hand OA BUT did not recognize and report 
any joints affected. Because of this false-negative problem, we 
redrew the illustrations and incorporated a self-exam step. Us- 
ing the second survey on n = 119 subjects, there was less un- 
derreporting: mean reported DIPs 2.5, mean 4.6 by exam. Tetra- 
choric/polychoric orrelation with the second survey improved to 
0.8, and mean negative predictive value for OA target joints im- 
proved to 86%. Multivariate modeling was done to control for con- 
founding sex and age effects; the dependent variable was ACR 
Hand OA, while the survey responses were used as independent 
variables. The second survey had apparently higher ORs than 
the first (see Table 1). Using the second survey ORs, one who 
has hand pain more than three times during the previous year 
AND reports two DIPs involved is much more likely to have ACR 
Hand OA than someone who reports no pain and no OA features 
(OR > 2,000). 
Table 1. Stepwise-selected predictors of ACR Hand OA 
(second survey with self-exam) 
Self report of: OR (95% CI) p 
Pain > 3 times >999 (22 to >999) 0.0031 
no. DIPs involved 6.3 (1.9 to 20.3) 0.0023 
no. PIPs involved 3.0 (1.3 to 7.1) 0.0100 
Conclusion: While this screening survey does not obviate need 
for careful subject characterization, a simple self-administered 
questionnaire like this may aid screening large populations for 
subject subsets likely to represent cases or controls. 
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Flexion contracture (FC), the inability to fully extend the knee, 
may be present in knee OA. Loss of extension reduces fit and 
contact area of opposing joint surfaces, which increases local 
cartilage stress and may contribute to OA progression. A bent- 
knee gait may increase patellofemoral load. Our goals were to: 1 ) 
test the hypothesis that baseline FC increases risk of tibiofemoral 
and patellofemoral OA progression in the next 18 months; 2) ex- 
plore location and severity of tissue lesions in knees with FC; 3) 
examine the relationship of FC to pain and function. 
300 persons (71% women, mean age 72, BMI 31) with knee OA 
(K/L _> 2 in at least one knee and symptoms) had baseline FC go- 
niometric measurement, and baseline and 18-month semi-flexed 
knee x-rays with fluoro confirmation. OA progression was defined 
as worsening of joint space grade. The MRI protocol included T1- 
weighted spin-echo (SE), sagittal fat-suppressed dual-echo turbo 
SE, and axial and coronal fat-suppressed, Tl-weighted 3D-fast 
low angle shot (FLASH) sequences. Cartilage, osteophytes, bone 
edema, cysts, and menisci were scored. Function was assessed 
with the WOMAC function scale and chair-stand performance, 
and pain severity with VAS for each knee. From logistic regres- 
sion using GEE, odds ratios (OR) and 95% CI for OA progres- 
sion associated with FC presence were estimated after excluding 
knees with advanced OA. 
The presence of FC significantly increased likelihood of tibio- 
femoral OA progression (see table), an effect that was stronger 
in the lateral tibiofemoral compartment. FC did not increase odds 
